Invo Bioscience Stock Probability of Future Stock Price Finishing Over 5.0

INVO Stock  USD 1.52  0.30  16.48%   
INVO Bioscience's future price is the expected price of INVO Bioscience instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of INVO Bioscience performance during a given time horizon utilizing its historical volatility. Check out INVO Bioscience Backtesting, INVO Bioscience Valuation, INVO Bioscience Correlation, INVO Bioscience Hype Analysis, INVO Bioscience Volatility, INVO Bioscience History as well as INVO Bioscience Performance.
To learn how to invest in INVO Stock, please use our How to Invest in INVO Bioscience guide.
  
At this time, INVO Bioscience's Price Book Value Ratio is very stable compared to the past year. As of the 19th of April 2024, Price To Book Ratio is likely to grow to 2.49, while Price To Sales Ratio is likely to drop 0.66. Please specify INVO Bioscience's target price for which you would like INVO Bioscience odds to be computed.

INVO Bioscience Target Price Odds to finish over 5.0

The tendency of INVO Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 5.00  or more in 90 days
 1.52 90 days 5.00 
close to zero percent
Based on a normal probability distribution, the odds of INVO Bioscience to move over $ 5.00  or more in 90 days from now is close to zero percent (This INVO Bioscience probability density function shows the probability of INVO Stock to fall within a particular range of prices over 90 days) . Probability of INVO Bioscience price to stay between its current price of $ 1.52  and $ 5.00  at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.32 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, INVO Bioscience will likely underperform. Moreover INVO Bioscience has an alpha of 1.4529, implying that it can generate a 1.45 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   INVO Bioscience Price Density   
       Price  

Predictive Modules for INVO Bioscience

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as INVO Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of INVO Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.081.5420.18
Details
Intrinsic
Valuation
LowRealHigh
0.306.0724.71
Details
Naive
Forecast
LowNextHigh
0.041.8520.49
Details
1 Analysts
Consensus
LowTargetHigh
18.2020.0022.20
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as INVO Bioscience. Your research has to be compared to or analyzed against INVO Bioscience's peers to derive any actionable benefits. When done correctly, INVO Bioscience's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in INVO Bioscience.

INVO Bioscience Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. INVO Bioscience is not an exception. The market had few large corrections towards the INVO Bioscience's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold INVO Bioscience, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of INVO Bioscience within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
1.45
β
Beta against NYSE Composite1.32
σ
Overall volatility
0.17
Ir
Information ratio 0.08

INVO Bioscience Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of INVO Bioscience for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for INVO Bioscience can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
INVO Bioscience is way too risky over 90 days horizon
INVO Bioscience may become a speculative penny stock
INVO Bioscience appears to be risky and price may revert if volatility continues
INVO Bioscience has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 3.02 M. Net Loss for the year was (8.03 M) with profit before overhead, payroll, taxes, and interest of 535.27 K.
INVO Bioscience currently holds about 1.96 M in cash with (4.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
INVO Bioscience has a frail financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Insider Trading

INVO Bioscience Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of INVO Stock often depends not only on the future outlook of the current and potential INVO Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. INVO Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.6 M
Cash And Short Term Investments232.4 K

INVO Bioscience Technical Analysis

INVO Bioscience's future price can be derived by breaking down and analyzing its technical indicators over time. INVO Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of INVO Bioscience. In general, you should focus on analyzing INVO Stock price patterns and their correlations with different microeconomic environments and drivers.

INVO Bioscience Predictive Forecast Models

INVO Bioscience's time-series forecasting models is one of many INVO Bioscience's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary INVO Bioscience's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about INVO Bioscience

Checking the ongoing alerts about INVO Bioscience for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for INVO Bioscience help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
INVO Bioscience is way too risky over 90 days horizon
INVO Bioscience may become a speculative penny stock
INVO Bioscience appears to be risky and price may revert if volatility continues
INVO Bioscience has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 3.02 M. Net Loss for the year was (8.03 M) with profit before overhead, payroll, taxes, and interest of 535.27 K.
INVO Bioscience currently holds about 1.96 M in cash with (4.76 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
INVO Bioscience has a frail financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Insider Trading
When determining whether INVO Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of INVO Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Invo Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Invo Bioscience Stock:

Complementary Tools for INVO Stock analysis

When running INVO Bioscience's price analysis, check to measure INVO Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INVO Bioscience is operating at the current time. Most of INVO Bioscience's value examination focuses on studying past and present price action to predict the probability of INVO Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INVO Bioscience's price. Additionally, you may evaluate how the addition of INVO Bioscience to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is INVO Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INVO Bioscience. If investors know INVO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INVO Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.34)
Revenue Per Share
2.043
Quarterly Revenue Growth
3.143
Return On Assets
(0.41)
Return On Equity
(10.61)
The market value of INVO Bioscience is measured differently than its book value, which is the value of INVO that is recorded on the company's balance sheet. Investors also form their own opinion of INVO Bioscience's value that differs from its market value or its book value, called intrinsic value, which is INVO Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INVO Bioscience's market value can be influenced by many factors that don't directly affect INVO Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INVO Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if INVO Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INVO Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.